EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre‐ and Post–COVID‐19 in Sweden—An Interrupted Time Series Study

Salar Mousa iD, Katarina Persson iD, Maria Palmetun-Ekbäck iD, Fredrik Nyberg iD, Huiqi Li iD, Björn Wettermark iD, MohammadHossein Hajiebrahimi iD

Basic & Clinical Pharmacology & Toxicology · 2026

DOI: 10.1111/bcpt.70213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2026. Verfasst von Salar Mousa und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. Hauptthemen laut MEDLINE: Stroke, Fibrinolytic Agents, COVID-19. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Svenska Forskningsrådet Formas, Hjärt-Lungfonden, Forskningsrådet om Hälsa, Arbetsliv och Välfärd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antithrombotic therapy constitutes a critical part of stroke management, and its utilization serves as an important indicator in the assessment of stroke care. However, knowledge on how the pandemic influenced the antithrombotic utilization after stroke remains limited.

Objective

This study aims to investigate the impact of the COVID‐19 pandemic on the initiation of antithrombotic agents after stroke in Sweden.

Design

Using nationwide linked Swedish health registers, we conducted an interrupted time series analysis (ITSA) using generalized linear model (binomial distribution, logit link). We estimated monthly trends in the initiation of antithrombotic drugs among new stroke patients between January 2019 and April 2024, with the pandemic intervention point set in March 2020. Key Results The monthly number of stroke cases declined significantly by 107 cases per month. No significant changes were observed in the total antithrombotic initiation. Antiplatelets showed a significant pre‐pandemic increasing trend (OR = 1.011 per month, 95% CI: 1.003 to 1.020), an immediate level increase at onset (OR = 1.150, 95% CI: 1.067 to 1.259) and a post‐intervention decline (OR = 0.991 per month, 95% CI: 0.981 to 0.998). Factor Xa inhibitors use increased post‐intervention (OR = 1.004, 95% CI: 1.002 to 1.006), while warfarin (OR = 0.990, 95% CI: 0.981 to 0.999) and dabigatran (OR = 0.991, 95% CI: 0.986 to 0.997) decreased.

Conclusions

The COVID‐19 pandemic had no impact on the overall use of antithrombotic agents. However, a short‐term increase in antiplatelet initiation and long‐term changes in warfarin, dabigatran, and factor Xa initiations were observed after the COVID‐19 outbreak.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeFibrinolytic AgentsCOVID-19HumansSwedenFemaleMaleInterrupted Time Series AnalysisAgedRegistriesPlatelet Aggregation InhibitorsAged, 80 and overMiddle Aged

Stichwörter der Autor:innen

COVID‐19Swedenantithrombotic therapydrug utilizationstroke

Substanzen

Fibrinolytic AgentsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Pharmacology and Therapeutic Department, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Pharmacoepidemiology Unit, Department of Pharmacy, Uppsala University, Uppsala, Sweden.

ORCID-Profile: Salar Mousa, Katarina Persson, Maria Palmetun-Ekbäck, Fredrik Nyberg, Huiqi Li, Björn Wettermark, MohammadHossein Hajiebrahimi

Förderung

  • Svenska Forskningsrådet Formas
  • Hjärt-Lungfonden
  • Forskningsrådet om Hälsa, Arbetsliv och Välfärd

Zitieren

APA

Mousa, S., Persson, K., Palmetun-Ekbäck, M., Nyberg, F., Li, H., Wettermark, B., & Hajiebrahimi, M. (2026). Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre‐ and Post–COVID‐19 in Sweden—An Interrupted Time Series Study. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70213

Vancouver

Mousa S, Persson K, Palmetun-Ekbäck M, Nyberg F, Li H, Wettermark B, et al. Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre‐ and Post–COVID‐19 in Sweden—An Interrupted Time Series Study. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70213

BibTeX
@article{Mousa2026,
  author = {Mousa, Salar and Persson, Katarina and Palmetun-Ekbäck, Maria and Nyberg, Fredrik and Li, Huiqi and Wettermark, Björn and Hajiebrahimi, MohammadHossein},
  title = {Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre‐ and Post–COVID‐19 in Sweden—An Interrupted Time Series Study},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  doi = {10.1111/bcpt.70213}
}
Kostenlos starten →